Insmed Inc (NAS:INSM)
$ 69.3 1.21 (1.78%) Market Cap: 12.40 Bil Enterprise Value: 11.80 Bil PE Ratio: 0 PB Ratio: 25.67 GF Score: 63/100

Q2 2019 Insmed Inc Earnings Call Transcript

Aug 01, 2019 / 12:30PM GMT
Release Date Price: $19.24 (-12.35%)
Operator

Good day, ladies and gentlemen, and welcome to the Insmed conference call to discuss company second quarter financial results. (Operator Instructions) As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conference, Mr. Blaine Davis, Head of Investor Relations. You may begin, sir.

Blaine T. Davis
Insmed Incorporated - VP & Head of IR

Thanks, Nancy. Good morning, everyone, and welcome to today's conference call to discuss our second quarter financial results for 2019.

Before we start, let me remind you that today's call will include forward-looking statements based on current expectations. Such statements represent our judgment as of today and may involve risks and uncertainties that may cause actual results to differ from the results discussed in the forward-looking statements. Please refer to our filings with the SEC, which are available through the SEC's website at www.sec.gov or from our website, for information concerning the risk

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot